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Abstract: Pomegranate fruit is a functional food of high interest for human health due to its wide
range of phytochemicals with antioxidant properties are implicated in the prevention of inflammation
and cancer. Ellagitannins, such as punicalagin and ellagic acid, play a role as anti-atherogenic and
neuroprotective molecules in the complex fighting against the degenerative diseases. The aim of this
work was to evaluate the composition in punicalagins and ellagic acid of differently obtained extracts
from whole fruit, peels and juices, prepared by squeezing or by centrifugation, of pomegranate
belonging to different cultivars. Moreover, a wider phenolic fingerprint was also determined.
The bioactivity of the extracts was tested on the redox activity of PDIA3 disulfide isomerase, an
enzyme involved in the regulation of several cellular functions and associated with different diseases
such as cancer, prion disorders, Alzheimer’s and Parkinson’s diseases. The results demonstrate that
the different ratios between punicalagin and ellagic acid modulate the enzyme activity and other
ellagitannins could interfere with this activity.
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1. Introduction
The increasing awareness of the role played by foods and of the relationship between nutrition
and health has raised the attention level toward their potential in the prevention of degenerative
and chronic ailments. Consumers are increasingly oriented to look for a better lifestyle comprising
correct behaviors in dietary choices. It is well known that degenerative illnesses, firstly cardiovascular
diseases, represent the leading causes of death in industrialized countries and that diabetes and relative
comorbidities are disabling and undermine well-being by lowering life expectancy.
Today’s worldwide dietary guidelines are based on the daily consumption of plant foods
rich in phytochemicals able not only to prevent these pathologies but also to maintain a general
state of health [1]. Scientific evidence has correlated a high intake of fruits and vegetables rich in
phenolic compounds in the protection against cerebrovascular diseases, coronary heart disorders and
neurodegenerative diseases [2–4]. Polyphenols exert a generic antioxidant and free radical scavenging
role next to specific biological properties including anti-inflammatory and anticancer activity modulated
by the antiproliferative and antimetastatic effects beyond the regulation of gene expression [5].
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Among foods with recognized healthy properties, and belonging to plant-based diet, a dominant
role is represented by the pomegranate. Fruits from Punica granatum L. represent a typical food of the
Mediterranean area, with a tradition historically proven by authoritative ancient sources. Extensively
used in the traditional medicine, the three parts of this fruit—the inedible exocarp and mesocarp (peels)
and the edible endocarp made by pulp and seeds (arils)—are rich in interesting bioactive molecules,
which have been the subjects of many studies in recent years [6,7]. In particular, pomegranate
peels represent about the 50% of the whole fruit and are a rich source of phenolics, flavonoids and
ellagitannins, such as punicalagins, punicalin, gallagic acid, ellagic acid and relative glycosides [8,9].
Recent clinical studies indicate that pomegranates may improve memory functioning and decrease
the risk of ischemic stroke [10] and a recent review reports the many potentials of ellagic acid,
which exerts cardiovascular and anti-cancer, anti-obesity, antimicrobial, antiviral and antioxidant
activities [11,12]. This small molecule is able to reduce the lipidemic profile and lipid metabolism,
modulate pro-inflammatory mediators (tumor necrosis factor-α, interleukin-1β, interleukin-6), and
decrease the activity of nuclear factor-κB while increasing nuclear factor 2 erythroid-2 related, playing
a pivotal role in anti-atherogenic, anti-inflammatory, and neuroprotective effects [13].
Moreover, among the European Community priorities, the first point is actually represented by
“jobs, growth and investment”, and one of the first recognized critical points of these policy areas is the
attainment of a circular economy; a goal to reach by helping “European business and consumers to make
the transition to a strong and more circular economy, where resources are used in a more sustainable
way”. By this point of view, pomegranate peels possess a very high added value, as they represent one
of the most valuable by-products of the food industry in terms of ellagitannins [14]. A particularly high
punicalagin content (up to about 120 mg/g dry matter) in the pomegranate peels has been reported in
the literature [15]. Moreover, peel extracts have recently raised a great interest for their potential use
as nutraceuticals or in dietary supplement and, in particular, punicalagin extraction by co-products of
pomegranate juice preparation could represent an interesting goal as this polyphenolic component is
widely taken into consideration given the wide spectrum of health-promoting activities exerted [16,17].
Despite several phytochemicals found in pomegranate fruits and moreover in peels being recognized
as molecules counteracting oxidative stress and preventing some major diseases, their biological targets
remain unclear. Then, the investigation of these biological targets could open a new research field in
order to clarify the phytochemicals biological mechanisms.
In this regard, it has been repeatedly reported that the protein disulfide isomerase 3 (PDIA3) can
be modulated by several types of polyphenols in different pathological conditions [18,19]. In vitro
studies have shown that PDIA3 can interact with several macromolecules and small ligands, such as
green tea catechins and flavonoids [20–22]. More recently, it has been demonstrated that punicalagin,
alone as a single and pure component, can bind to PDIA3 and is a non-competitive inhibitor of PDIA3
reductase activity with an inhibition constant within the micromolar range [23]. PDIA3 is a protein
mainly localized into the endoplasmic reticulum but, differently to others PDIs, PDIA3 is also present
on the cellular surface and in other cellular compartments [24] and hence represents an attractive
biological target for natural compounds.
PDIA3 is also involved in several cellular functions and consequently associated with different
human diseases such as cancer, prion disorders, Alzheimer’s and Parkinson’s diseases [25–28].
Its structure is characterized by four thioredoxin-like domains, namely a, b, b’ and a’. The a and
a’ domains contain the catalytic active sites constituted by the tetrapeptide Cys-Gly-His-Cys, which
provides PDIA3 with redox activity, while b and b’ domains are redox inactive but are required for the
PDIA3 complete activity [24,29].
Furthermore, PDIA3 is present on the platelet surface [30], where it is involved in platelet
aggregation due to its redox activity towards the β3 integrin, a subunit of the fibrinogen receptor
αIIbβ3, and induces a new pattern of disulfide bond formation. In fact, under thrombin stimulation,
the fibrinogen receptor αIIbβ3 on the platelets surface requires several conformational changes to
drive platelet activation [31–34]. Since the role of PDIA3 in platelet aggregation is well-known, many
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researchers are focusing on its possible inhibition [35]. Thus, the search of PDIA3 modulators could be
interesting and pomegranate extracts can be a good source of these compounds.
In light of these interesting fields, the rationale of this work was to recover and valorize the
co-products of agro-industrial processes, with the final goal of obtaining interesting biomolecules to
use as pharmaceutics or with nutritional, nutraceutical and cosmetic health purposes. Indeed, this
work provides information to confirm and extend the already obtained data exploiting the properties
of the pomegranate fruit peel that generally represents a waste of pomegranate juice preparation, even
though it contains significant amounts of phenolic bioactive compounds.
To achieve such goal, we focused our efforts on realizing different extracts from diversely
worked-up pomegranates, optimizing the extraction procedure of the bioactive compounds of interest
in order not only to obtain extracts enriched in polyphenols but also characterized by a different
peculiar composition and finally, evaluating their effects as possible PDIA3 modulators. With this
aim, we selected different pomegranate fruits coming from several Italian districts and belonging to
different cultivars which were submitted to different work-up and extraction techniques. The resulting
extracts, evaluated in their quali-quantitative composition by two different HPLC-DAD analyses, were
then tested for their biological activity in terms of inhibition effect on PDIA3 reductase activity.
2. Materials and Methods
2.1. Materials
Bidistilled water, ethanol, 85% formic acid, ethyl acetate, glacial acetic acid, dimethyl sulfoxide
(DMSO), acetonitrile RS for HPLC, punicalagin (≥98%), ellagic acid (≥95%), phosphate buffered saline
(PBS), dithiothreitol (DTT), oxidized glutathione (GSSG) and eosin isothiocyanate were purchased
from Sigma (Milan, Italy). EDTA (0.5 M solution pH 8.0) from IBI Scientific (Dubuque, Iowa).
Pomegranate fruits of cv. Mollar (Ml) were obtained from an Italian market. Some fruits of Italian
origin, belonging to two sub-varieties of cv. Dente di Cavallo (DC1 and DC2) with a difference of
about two weeks in the maturation stage and harvest time, were provided by a local supplier (Azienda
Biologica Giovomel, Avellino, Italy). A pomegranate variety from Mozia island (South Italy) was
provided by the “Missione Archeologica Mozia” of “Sapienza” University of Rome (Mz).
2.2. Samples Preparation
Whole fruits (F) or separated into two parts: arils and peels (exocarp and mesocarp) were washed,
mixed for 30 s and submitted to the extraction procedure. Peels (P), manually separated from washed
fruits, were blended in a mixer for 30 s and submitted to the extraction procedure. Juices were prepared
from whole fruit by squeezing (S) or from arils by centrifugation (C).
2.3. Extraction Methods
2.3.1. Whole Fruit or Peels Extraction with Ethanol and Acidified Water
All samples (F and P) were submitted to the extraction procedure as previously described in
Reference [7]. In brief, 10 g was blended and extracted with 40 mL ethanol:acidified water (5% acetic
acid) in 3:1 (v:v) ratio by stirring for 24 h at room temperature in the dark. The extraction mixture was
decanted, filtered on paper, evaporated at 40 ◦C in the dark under vacuum and immediately analyzed
or stored at 4 ◦C.
2.3.2. Juice Extraction with Ethanol
Squeezed or centrifuged juice (2 mL) was submitted to extraction with ethanol (6 mL) under
stirring at room temperature in the dark for 24 h. The extraction mixture, decanted and filtered on
paper, was evaporated at 40 ◦C in the dark under vacuum and immediately analyzed or stored at 4 ◦C.
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2.3.3. Partitioning in Ethyl Acetate
The so-obtained dried extracts, dissolved in 10 mL of water, were extracted thrice in a separating
funnel with 10 mL of ethyl acetate, freeze-dried or evaporated at 40 ◦C under vacuum in the dark.
The samples were immediately analyzed or stored at 4 ◦C.
2.4. HPLC-DAD Analyses
Dried extracts were weighed, dissolved in DMSO or water and filtered before injection into an
HPLC Perkin Elmer apparatus (Waltham, MA, USA) consisting of a Series 200 LC pump, a Series
200 DAD and a Series 200 autosampler, including a Totalchrom Perkin Elmer software for the data
acquisition. Chromatography was performed on a Luna RP18 column (250 × 4.6 mm i.d., 5 µm) using
a mobile phase made by acetonitrile and water acidified by 5% formic acid, in gradient with a flow
rate of 1 mL/min, at 360 and 530 nm. Punicalagin anomers α and β and ellagic acid were quantified
as previously described [7]. The multi-component phenolic fingerprint was also studied for the most
promising pomegranate extracts (DC and Mz) according to a validated method as reported in the
Supplementary Materials [36].
2.5. PDIA3 Purification and Disulfide Reductase Activity Determination
2.5.1. Protein Expression and Purification
Human recombinant PDIA3 was cloned into a pET21 vector (Novagen) and expressed in E. coli
strain BL21 as previously described [37]. Protein was purified by ammonium sulphate fractionation,
ion exchange and heparin chromatography [38,39]. Protein purification was evaluated by SDS-PAGE
and its concentration was spectrophotometrically determined (ε280 reduced form = 44,810 M−1·cm−1).
2.5.2. Determination of Protein Disulfide Reductase Activity
Disulfide reductase activity of PDIA3 was evaluated by sensitive fluorescent assay using dieosin
glutathione disulfide (DiE-GSSG) as a fluorogenic probe. DiE-GSSG was synthesized by the reaction
of eosin isothiocyanate with oxidized glutathione [40] with some modifications [20]. DiE-GSSG
purification was carried out by HPLC and its concentration was determined spectrophotometrically
(ε525 = 88,000 M−1·cm−1). A sample from each dried pomegranate extract (50 µL), from the peel and
whole fruit of the different cultivars (Ml, Mz, DC1 and DC2, respectively), was dissolved in 100 µL
of ultrapure water at a final concentration of 500 mg/mL. Their effects on PDIA3 disulfide reductase
activity were evaluated, using DiE-GSSG 200 nM, PDIA3 20 nM, DTT 5 µM in reaction buffer (PBS
and EDTA 0.2 mM). All tested extracts were tested at final concentrations of 666.0, 66.0, 6.60 and
0.66 µg/mL with a two-minute incubation before the analysis. GSSG reduction was monitored for
3 min at 545 nm, with excitation at 520 nm, at 25 ◦C under continuous stirring. Enzymatic activity
was evaluated by fitting the slope of the initial fluorescence increase. The percentage of the inhibition
was expressed as a residual activity in presence of the extracts compared to PDIA3 alone. IC50 was
evaluated by fitting the inhibition effects vs. extracts concentration using the GraphPad Prism 7.0
software (GraphPad Software, San Diego, CA, USA).
2.6. Statistical Analysis
Each assay was replicated at least three times. Data are expressed as mean ± SEM and statistical
significance was determined using the GraphPad Prism 7.0 software (GraphPad Software, San Diego,
CA, USA).
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3. Results
3.1. Polyphenols Extraction
Fully ripe pomegranate fruits coming from different geographic origins and belonging to several
cultivars selected as previously described in the section “Material and methods” (Mz, Ml, DC1, DC2),
were supplied. These were characterized by different organoleptic quality (color and size, flavor,
harvest dates, peel texture and thickness), and were submitted to different work-up with the aim
to obtain products with diverse ellagitannin composition. Whole fruits were homogenized (F) or
squeezed (S); separated peels were homogenized (P), separated arils were centrifuged (C). The resulting
homogenates and juices were submitted to a mild extraction method, by a simple ethanol/water
mixture, which grants a high yield in polyphenolic extraction, as previously reported [7]. All of the
samples were submitted to hydroalcoholic extraction which yields range among 8–19% by dry weight
in whole fruit, most likely in relation to the not evaluated sugar content but are not directly correlated
to the polyphenolic content, as shown below by HPLC analyses. The range, only apparently similar
for the peels (12–19%), assumes a different means because, in this case, sugars are almost completely
absent. On the contrary, the extraction yields from juices showed a narrow range between 15–16%
mainly accounting for the sugar content of the edible part.
The dried extracts obtained from these experiments were then extracted with a partitioning
system made of water and ethyl acetate, which allows a preferential distribution of punicalagin in the
aqueous phase and of ellagic acid, much less represented, in the organic phase of medium polarity.
The extraction yields account for the partitioning of about 95% in the aqueous fraction and only a small
part in the organic phase that accounts for a maximum of 6.2% in the sample P-DC2.
3.2. Quali-Quantitative Analysis of the Polyphenolic Fraction
The variability shown by the samples was taken into account, in terms of extraction yields of
hydroalcoholic extracts, is highly significant in regards to the differences existing among geographic
provenance, cultivars and even sub-varieties grown in the same geographic and pedoclimatic
conditions but only the quali-quantitative profile obtained by HPLC-DAD analyses could show
the real differences in terms of polyphenolics, and specifically for ellagitannins. Important differences
could already be revealed by a simple glance to the chromatograms of the hydroalcoholic extracts
(Figure 1) recorded at 360 nm, which show the dominant presence of punicalagin α and β anomers,
followed by a lower ellagic content but also, in some cases (as for example in the Mz sample), of other
non-negligible molecules.
The quantification of punicalagins as sum of anomers, reported as mg/g by dry extract (Table 1),
evidenced relevant differences, in the range 5–16 mg/g dry aqueous extracts by fruit, 16–30 mg/g
of aqueous extracts by peels and in amounts around or much less than 1 mg in the aqueous extracts
by squeezed or centrifuged juices. In addition, if the values were very low, significant differences
could be shown among the two kinds of applied work-up. Juices obtained by squeezing of the whole
fruit show punicalagin and ellagic acid contents of about 17- and 2-fold respect to juices obtained
by centrifugation of separated arils. The ellagic acid is concentrated in the organic phase in which it
could reach contents of 37 mg/g dry extract (P-Mz). Taking into account the overall quantity of the
extracts, we could evaluate the content of punicalagin ranging between 150 and 500 mg/100 g and of
ellagic acid ranging between 15 and 65 mg/100 g of fresh homogenized peels which largely justify the
employment of this matrix for the extraction of such a valuable moiety. Indeed, punicalagin seems to
reach a high concentration in the organic phase, in which only the ellagitannin fraction is selectively
extracted, but the 73.5 mg/g dry extract (P-Ml) of the richest sample correspond, taking into account
the extract yield of 0.36%, only to an absolute quantity of about 25 mg/100 g fresh homogenized peels.
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Table 1. Quali–quantitative analyses of the two studied metabolites in the differently obtained
pomegranate extracts.
Sample
Hydroalcoholic (HA) Water (W) Organic
Punicalagin Ellagic Acid Punicalagin Ellagic Acid Puni lagin Ellagic Acid
F-DC1 - - 5.13 ± 0.11 0.07 ± 0.02 - -
P-DC1 - - 25.9 ± 0.02 0.76 ± 0.07 - -
C-DC1 - - 0.05 ± 0.02 0.006 ± 0.003 - -
S-DC1 - - 1.26 ± 0.10 0.017 ± 0.003 - -
F-DC2 - - 6.53 ± 0.09 0.22 ± 0.09 - -
P-DC2 - - 16.2 ± 0.01 0.80 ± 0.04 - -
C-DC2 - - .06 ± 0.04 0.007 ± 0.004 - -
S-DC2 - - 0.72 ± 0.05 0.008 ± 0.004 - -
F-Mz 11.2 ± 0.11 1.57 ± 0.02 10.4 ± 0.12 0.34 ± 0.08 36.7 ± 0.20 24.6 ± 0.13
P-Mz 25.7 ± 0.24 3.40 ± 0.19 24.9 ± 0.05 1.08 ± 0.13 35.1 ± 0.14 37.4 ± 0.05
F-Ml 19.1 ± 0.20 0.59 ± 0.03 15.8 ± 0.15 0.32 ± 0.07 54.8 ± 0.26 14.7 ± 0.09
P-Ml 32.2 ± 0.35 1.0 ± 0.25 30.3 ± 0.17 0.40 ± 0.08 73.5 ± 0.58 7.8 ± 0.06
C-Ml 0.06 ± 0.03 0.012 ± 0.003 0.05 ± 0.01 0.007 ± 0.002 BLD * 2.45 ± 0.50
S-Ml 0.85 ± 0.45 0.026 ± 0.007 0.79 ± 0.07 0.01 ± 0.009 BLD * 1.25 ± 0.30
* BLD: Below Limit of Detection.
To further analyze the presence of other important phytochemicals in these extracts, we carried
out an analysis of the multi-component phenolic pattern by a validated HPLC method. We looked
for twenty-two secondary metabolites abundant in the plant kingdom. Surprisingly, few of them
were detected and quantitated in some extracts. Pomegranate peel was richer in phenolic compounds
than the whole fruit (~2-fold for Mz and ~11-fold for DC1 samples). Conversely, we found an
opposite profile in F-DC2. The most characterizing compounds were rutin and catechin. Moreover,
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3-hydroxy-4-methoxybenzaldehyde was only present in P-DC1, whereas P-Mz showed small amounts
of 2,3-dimethoxy benzoic acid and benzoic acid. Finally, F-Mz was characterized by the presence
of vanillic acid (Tables S1 and S2, Supplementary Materials). An important aspect to be considered
is that both pomegranate treatments (centrifugation and squeezing) led to a complete loss of these
secondary metabolites.
3.3. Pomegranate Extract Effects on Disulfide Redox Activity of the PDIA3
Pomegranate extracts by whole fruit, separated peels, squeezed and centrifuged juices from
samples DC1 and DC2 were tested on PDIA3 redox activity. Decreasing amounts of selected extracts
were added to the reaction mixture solution, to a final concentration ranging from 666 to 3.33 µg/mL,
and PDIA3 residual activity was assayed. Generally, as shown in Figure 2, only peel and whole
fruit aqueous extracts were able to significantly inhibit the PDIA3 redox activity in a dose-dependent
manner, while juices, either prepared by squeezing or centrifugation, show inhibition only at the
highest concentrations. For this reason, we extended the analysis only to peel and whole fruit extracts
of the other selected samples; testing their activity at a concentration ranging from 666 to 0.66 µg/mL
(Figure 3). Aqueous peel extracts, P-Ml, P-Mz, P-DC1 and P-DC2 always resulted in a higher capacity
of PDIA3 inhibition compared to their corresponding aqueous whole fruit extracts, F-Ml, F-Mz, F-DC1
and F-DC2 respectively, even though at a higher concentration, completely inhibit the protein activity
(Figure 3, confirming the high potency of Mollar cultivar respect to the other ones (Figure 3d).Nutrients 2018, 10, x FOR PEER REVIEW  8 of 14 
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of this molecule seems not greatly affected when it is tested in a mixture with other ellagitannin
components. On the contrary, assuming that the observed inhibitory effect is just related to punicalagin,
the IC50 calculated on the basis of punicalagin content of each extract tested is always below 0.1 µM,
strongly supporting a synergic effect between punicalagin and other components present in the extract.
Table 2. Punicalagin relative effects on PDIA3 in hydroalcoholic (HA) and water (W) extracts after partitioning.
Sample
Hydroalcoholic (HA) Water (W)
From Table 1 Calculated From Table 1 Calculated
Pun/extr
mg/g
IC50 extr
mg/L
IC50 Pun
µg/L
IC50 Pun
µM
Pun/extr
mg/g
IC50 extr
mg/L
IC50 Pun
µg/L
IC50 Pun
µM
A B AxB AxB/MW A B AxB AxB/MW
F-Mz 11.2 15.07 168.8 0.156 10.4 10.54 109.2 0.101
P-Mz 25.7 4.69 120.3 0.111 24.9 3.48 86.7 0.080
F-Ml 19.1 9.78 186.8 0.172 15.8 2.53 40.0 0.037
P-Ml 32.2 6.00 193.2 0.178 30.3 0.69 20.9 0.019
F-DC1 - - - - 5.13 5.87 30.2 0.028
P-DC1 - - - - 25.88 3.42 88.6 0.082
F-DC2 - - - - 6.53 3.4 22.2 0.020
P-DC2 - - - - 16.14 1.37 22.2 0.020
4. Discussion
Given the rising interest for the biological properties exerted by pomegranate ellagitannin
component and the related healthy aspects, the aim of this work was to evaluate the application of a
simple and mild extraction procedure to a matrix which can provide a high added value. The recovery
and valorization of the co-products of agro-industrial processes have the double advantage to recycle
waste, reducing the global impact, and to obtain interesting biomolecules to use as pharmaceutics
or with nutritional, nutraceutical and cosmetic healthy purposes [41]. Peels generally represent a
waste of pomegranate juice preparation, while containing significant amounts of phenolic bioactive
compounds, not only with antioxidant properties but also able to modulate protein activity as well as
the disulphide redox activity of the PDIA3, an interesting biological target.
In the present work, the possibility to obtain extracts containing several amounts of differently
purified ellagitannins represents a crucial starting point in the evaluation of the phytocomplex capacity
to interfere with biological activity, assessing in which way the different extract composition could
influence the protein activity. A very higher amount of ellagitannins was found, as expected, in
the peels respect to the whole fruit, but also differently work-up juices were analyzed with the
aim to highlight that simple domestic practices, such as fruit squeezing or arils centrifugation are,
could deeply influence the final content of biomolecules in a home-made beverage. The extraction
of homogenized whole fruit represents a medium content among the other evaluated samples and
accounts for all the different extractable components. The use of safe reagents, such as water, ethanol
and acetic acid, the easiness of processing and the reduced procedural costs, make the performed
work-up directly applied for the preparation of food supplements. The partitioning in water, essential
in our experimental design, to obtain differently distributed ellagitannin, may imply an expensive
freeze drying or an undesired spray drying step, detrimental to thermosensible molecules, but these
could be easily avoided if the aim is obtaining food supplements. The partitioning in ethyl acetate
is necessary only if ellagic acid should be more selectively extracted and concentrated, and although
considered acceptable for safe extraction techniques, this solvent should be removed very carefully
before human use. For this reason and also because of a response of less than the 10% of total extracted
punicalagin, the organic phase was not tested in the biological assays. It could become of interest only
in view of evaluating further the different ratios between punicalagin and ellagic acid, the last one
becoming comparable or preeminent in the acetate fraction.
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As previously shown, in some cultivars, punicalagin rises to amounts of 400–500 mg/100 g fresh
peels, representing an exceptionally high content of specific polyphenols such as ellagitannins are.
In the preparations obtained by peels, the ratio between punicalagin and ellagic acid varies in a very
wide range between 75:1 (P-Ml) in the aqueous extracts and 1:1 in the organic ones (P-Mz), up to
organic extracts from juices in which punicalagin is almost absent.
Both peel and whole fruit extracts are able to inhibit the PDIA3 redox activity in a dose-dependent
manner. The reported higher capacity on PDIA3 inhibition of the peel extracts could be due to the
higher punicalagin content respect to the corresponding whole fruit, supporting the hypothesis that
the inhibitory effect is mainly correlated to punicalagin. Indeed, analyzing the effect on PDIA3 activity
of both punicalagin and ellagic acid, alone as single and pure components, previously published data
showed a higher inhibitory effect of punicalagin compared to ellagic acid, although both molecules
can bind to PDIA3 with a not so high different affinity [23]. Hence, the present analysis carried out on
different pomegranate extracts, allowed us to test the effect of punicalagin and ellagic acid on PDIA3
activity directly from a natural mixture, evaluating the synergic or antagonist activity of these two
molecules which can be present in different ratios. In addition, this analysis allowed also to speculate
about the contribution of other species present into the extracts, besides punicalagin, in modulating
PDIA3 redox activity inhibitory.
Extracts of the same kind, obtained by a hydroalcoholic (HA) extraction system or after
partitioning of these in water (W), showed a different activity with the HA always less effective respect
to W. This is more evident in P-Ml, where peels extracted by W present a higher PDIA3 inhibition
activity respect to the HA (Table 2). This behavior could be correlated to the different punicalagin
content but also to the different punicalagin/ellagic acid ratio that can be associated with different
analytes distribution after partitioning in water (or in ethyl acetate). Indeed, the punicalagin/ellagic
acid ratio drastically increases in aqueous extract of the P-Ml (75:1) compared to corresponding
hydroalcoholic extract (32:1). Additionally, the aqueous P-Ml extract which shows the maximum
PDIA3 inhibition effect with an IC50 around 0.69 µg/mL, has the highest punicalagin/ellagic ratio.
A synergic effect may be expected since the inhibitory activity of the tested extracts seems always
higher than it would be expected considering only the punicalagin content. On the basis of data
reported in Table 2, a hypothetical value of IC50 can be calculated by assuming that punicalagin is
mainly responsible for the observed inhibitory effect and this is solely the result of the amount of
punicalagin present in each fraction tested. Considering that the IC50 value previously calculated for
punicalagin as the isolated component is within the micromolar range [23], the activity of this molecule
seems not negatively affected when it is present in a complex mixture with other components. On the
contrary, for all analyzed extracts, these hypothetical IC50 values were always smaller than the value
of IC50 previously calculated for punicalagin alone. This observation strongly supports a synergistic
effect due to the presence of other components in the analyzed extracts that are responsible for the
better inhibitory activity observed. Analyzing data reported in Table 2, water extract (W), further
considerations could be made. Ml extracts always appear more active than Mz ones, regardless of the
type of extract (whole fruit or peels). However, both Ml and Mz extracts show a similar ratio of about 3
between the IC50 (Extract, mg/L) of whole fruit and of peel (F-Ml/P-Ml = 2.53/0.69 and F-Mz/P-Mz =
10.54/3.48) demonstrating the higher activity of peel components, mostly related to the higher content
of punicalagin. When these extracts are compared for the hypothetical IC50, (Punic µg/L, amount of
punicalagin present in each extract), this ratio decreases to about 2 and 1.2, respectively (IC50 µM Punic
F-Ml/P-Ml = 0.037/0.019 and F-Mz/P-Mz = 0.101/0.080) indicating a similar synergistic effect, with
peel extracts appearing always more active than whole fruit ones and Ml cultivar extracts showing a
better inhibitory effect.
A different behavior can be instead observed for DC cultivar belonging to different sub-varieties,
(DC1 and DC2). Although the inhibitory effect of the peel extracts is always better than whole fruit,
DC2 shows a stronger activity than DC1 even if the P-DC2 extract is characterized by a lower content
of punicalagin. Comparing the IC50 of both DC2 extracts (F and P) with the Ml ones, DC2 extracts
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seems to be less active. However, the hypothetical IC50 calculated on the basis of punicalagin content
of both P-DC2 and F-DC2 are quite similar to the corresponding hypothetical IC50 calculated for the
P-Ml extract. So, while these data still support a synergism in the inhibitory effect due to the presence
of other components in the extracts, this effect is not the same among the analyzed cultivars, probably
as a result of a different composition. Additionally, for DC cultivar the sub-variety may play an
important role, affecting both the extract composition and punicalagin content as well as the observed
inhibitory effect.
Besides, all the considered aqueous extracts at 66 µg punicalagin/mL, inhibit almost completely
the protein activity with the exception of F-Mz, where a 30% residual activity is still observable. Thus,
Mz whole fruit extracts seem to be less effective in PDIA3 inhibition. Although F-DC2 and F-Mz have
similar punicalagin content and the same punicalagin/ellagic acid ratio, 30:1, they differ in PDIA3
inhibition activity. The F-Mz shows a different chromatographic profile in which several peaks not
present in other analyzed cultivars are detectable. From literature [42] four reported peaks, identified as
punicalagin-derivative, punicalagin-derivative, HHDP-hexoside and ellagic acid-O-pentoside, could
interfere in PDIA3 inhibition. Then, further studies will be necessary in order to better investigate the
effects of pomegranate components on PDIA3 activity and evaluate the activity of extracts obtained
from different cultivar or maturation stage.
Many studies suggest that PDIA3 is involved in multiple cellular functions through its specific
enzymatic activity and its wide binding capabilities, and these functions are not confined within the
endoplasmic reticulum. Moreover, considering the role of PDIA3 in several types of diseases, it could
become an important target for developing novel therapeutic strategies. Thus, the finding of strong
and specific PDIA3 inhibitors could open a new field in the treatment of these diseases and this study
opens the possibility to use pomegranate extract as a modulator of PDIA3 activity.
5. Conclusions
In an eco-sustainable context, a very simple hydroalcoholic extraction allows us to transform
by-products of pomegranate juice industry in interesting co-products with high added value. In our
opinion, the choice of this matrix and the biocompatible and economic adopted extraction technique
could be of high interest for the scientific community and for the food supplement industry.
We here report evidence that pomegranate extracts can inhibit/modulate the reductase activity
of PDIA3 as previously demonstrated for punicalagin. Considering the many cellular processes
involving PDIA3, healthy uses of pomegranate extracts deserve to be evaluated. In the light of the
recent reports showing that PDIA3 plays an important role in platelet aggregation, sperm maturation
and egg fertilization as its redox and chaperone activities of PDIA3 were important for these functions,
the reported inhibition effects of the differently obtained pomegranate extracts could be also useful for
future drug application and their relative development.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/11/1/186/s1,
HPLC-DAD method and equipment were described along with the quali-quantitative composition of the most
promising extracts (DC and Mz) in terms of specific phenolic compounds. Table S1. Multi-component phenolic
pattern of DC cultivars. Table S2. Multi-component phenolic pattern of Mz cultivar.
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